1. Home
  2. Labeler Index
  3. Rising Pharma Holdings, Inc.
  4. 64980-449
  5. NDC Package Code: 64980-449-07 Fingolimod

NDC Package 64980-449-07 Fingolimod

Fingolimod Hcl Capsule Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
64980-449-07
Package Description:
7 CAPSULE in 1 CARTON
Product Code:
64980-449
Proprietary Name:
Fingolimod
Non-Proprietary Name:
Fingolimod Hcl
Substance Name:
Fingolimod Hydrochloride
Usage Information:
This medication is used to treat multiple sclerosis-MS. It is not a cure for MS but it is thought to help by preventing immune system cells (lymphocytes) from attacking the nerves in your brain and spinal cord. It helps decrease the number of episodes of worsening and may prevent or delay disability.
11-Digit NDC Billing Format:
64980044907
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Rising Pharma Holdings, Inc.
Dosage Form:
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
FINGOLIMOD HYDROCHLORIDE .5 mg/1
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA207939
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
11-10-2021
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
64980-449-0330 CAPSULE in 1 BOTTLE
64980-449-2828 CAPSULE in 1 CARTON
64980-449-977 CAPSULE in 1 BLISTER PACK

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 64980-449-07?

The NDC Packaged Code 64980-449-07 is assigned to a package of 7 capsule in 1 carton of Fingolimod, a human prescription drug labeled by Rising Pharma Holdings, Inc.. The product's dosage form is capsule and is administered via oral form.

Is NDC 64980-449 included in the NDC Directory?

Yes, Fingolimod with product code 64980-449 is active and included in the NDC Directory. The product was first marketed by Rising Pharma Holdings, Inc. on November 10, 2021 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 64980-449-07?

The 11-digit format is 64980044907. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-264980-449-075-4-264980-0449-07